Glioblastoma Clinical Trials in Lebanon, New Hampshire
2 recruitingLebanon, New Hampshire
Showing 1–2 of 2 trials
Recruiting
Phase 2
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
Recurrent GlioblastomaProgressive Glioblastoma
National Cancer Institute (NCI)184 enrolled317 locationsNCT06325683
Recruiting
Not Applicable
Evaluation of the CONVIVO System
Brain MetastasesGlioblastomaMeningioma+3 more
Dartmouth-Hitchcock Medical Center30 enrolled1 locationNCT05139277